These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 26065452)

  • 1. The distribution of hepatitis B virus surface antigen polymorphisms at positions associated with vaccine escape.
    Raheel M; Choga WT; Blackard JT
    J Med Virol; 2020 Dec; 92(12):3336-3343. PubMed ID: 32104912
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of a breakthrough vaccine escape strain associated with overt hepatitis B virus infection.
    El-Mowafy M; Elegezy M; El-Mesery M; Elgaml A
    Virus Genes; 2024 Apr; 60(2):235-239. PubMed ID: 38349448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Neutralization of hepatitis B virus with vaccine-escape mutations by novel hepatitis B vaccine with large-HBs antigen].
    Kato T; Akari H
    Uirusu; 2023; 72(2):149-158. PubMed ID: 38220203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Last Ten Years of Advancements in Plant-Derived Recombinant Vaccines against Hepatitis B.
    Joung YH; Park SH; Moon KB; Jeon JH; Cho HS; Kim HS
    Int J Mol Sci; 2016 Oct; 17(10):. PubMed ID: 27754367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibody responses during hepatitis B viral infection.
    Ciupe SM; Ribeiro RM; Perelson AS
    PLoS Comput Biol; 2014 Jul; 10(7):e1003730. PubMed ID: 25078553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of unusual escape variants of hepatitis B virus isolated from a hepatitis B surface antigen-negative subject.
    Grethe S; Monazahian M; Böhme I; Thomssen R
    J Virol; 1998 Sep; 72(9):7692-6. PubMed ID: 9696878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Update on diagnosis, management, and prevention of hepatitis B virus infection.
    Mahoney FJ
    Clin Microbiol Rev; 1999 Apr; 12(2):351-66. PubMed ID: 10194463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of B Cell Repertoire Dynamics Following Hepatitis B Vaccination in Humans, and Enrichment of Vaccine-specific Antibody Sequences.
    Galson JD; Trück J; Fowler A; Clutterbuck EA; Münz M; Cerundolo V; Reinhard C; van der Most R; Pollard AJ; Lunter G; Kelly DF
    EBioMedicine; 2015 Dec; 2(12):2070-9. PubMed ID: 26844287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting hepatitis B vaccine escape using immunogenetics in Bangladeshi infants.
    Butler-Laporte G; Auckland K; Noor Z; Kabir M; Alam M; Carstensen T; Wojcik GL; Chong AY; Pomilla C; Noble JA; McDevitt SL; Smits G; Wareing S; van der Klis FR; Jeffery K; Kirkpatrick BD; Sirima S; Madhi S; Elliott A; Richards JB; Hill AV; Duggal P; ; Sandhu MS; Haque R; Petri WA; Mentzer AJ
    medRxiv; 2023 Jun; ():. PubMed ID: 37425840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Do HBsAg subdeterminants matter for vaccination against hepatitis B?
    Gerlich WH
    Virus Genes; 2024 Apr; 60(2):240-242. PubMed ID: 38353809
    [No Abstract]   [Full Text] [Related]  

  • 11. Neutralizing hepatitis B.
    Robbiani DF
    J Exp Med; 2020 Oct; 217(10):. PubMed ID: 32790869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis B virus vaccine breakthrough infection: surveillance of S gene mutants of HBV.
    Qin Y; Liao P
    Acta Virol; 2018; 62(2):115-121. PubMed ID: 29895151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Control of occult hepatitis B virus infection.
    Lalana Garcés M; Ortiz Pastor O; Solé Enrech G; Guerra-Ruiz AR; Casals Mercadal G; Almería Lafuente A; Ballesteros Vizoso MA; Medina PG; Salgüero Fernández S; Zamora Trillo A; Aured de la Serna I; Hurtado JC; Pérez-Del-Pulgar S; Forns X; Morales Ruiz M
    Adv Lab Med; 2022 Dec; 3(4):321-341. PubMed ID: 37363431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness of PCR primers for the detection of occult hepatitis B virus infection in Mexican patients.
    Sosa-Jurado F; Meléndez-Mena D; Rosas-Murrieta NH; Guzmán-Flores B; Mendoza-Torres MA; Barcenas-Villalobos R; Márquez-Domínguez L; Cortés-Hernández P; Reyes-Leyva J; Vallejo-Ruiz V; Santos-López G
    PLoS One; 2018; 13(10):e0205356. PubMed ID: 30304056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis B virus infection among institutionalized mentally ill patients in Brazil.
    Moraes TC; Fiaccadori FS; Souza M; Almeida TN; Cunha Mdos P; Castro Íde A; Cardoso Dd
    Braz J Infect Dis; 2015; 19(6):643-7. PubMed ID: 26361836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Escape mutants of hepatitis B virus].
    Jaramillo CM; Navas MC
    Rev Chilena Infectol; 2015 Apr; 32(2):190-7. PubMed ID: 26065452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaccine- and hepatitis B immune globulin-induced escape mutations of hepatitis B virus surface antigen.
    Cooreman MP; Leroux-Roels G; Paulij WP
    J Biomed Sci; 2001; 8(3):237-47. PubMed ID: 11385295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis B vaccination.
    Romanò L; Paladini S; Galli C; Raimondo G; Pollicino T; Zanetti AR
    Hum Vaccin Immunother; 2015; 11(1):53-7. PubMed ID: 25483515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low prevalence of hepatitis B vaccine escape mutants among individuals born after the initiation of a nationwide vaccination program in Iran.
    Aghasadeghi MR; Velayati AA; Mamishi S; Nabavi M; Aghakhani A; Bidari-Zerehpoosh F; Haghi Ashtiani MT; Sabeti S; Banifazl M; Azimian-Zavareh F; Motevalli F; Soleymani S; Ramezani A
    Arch Virol; 2016 Dec; 161(12):3405-3411. PubMed ID: 27613286
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.